Angiostatic agents
US5135920A · kind A · utility
18Cited by
14References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 1989 |
| Grant date | Aug 4, 1992 |
| Priority date | — |
| Expiry date | Nov 9, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Dextran sulfate, .beta.-1,3-glucan sulfate, and the salts thereof are angiostatic and useful for treatment and prevention of various diseases caused by abnormally accelerated angiogenesis. Combination of such a compound with a steroidal or non-steroidal substance increases the angiostatic activity of each compound to induce the combined effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.